References for this review were identified by searches of MEDLINE and PubMed from 1955 to February 2006, with the terms “idiopathic intracranial hypertension”, “benign intracranial hypertension”, “pseudomotor cerebri”, and “otitic hydrocephalus”. Additionally, we identified early references by hand searches of journals. Only papers published in English were reviewed. The final reference list was generated on the basis of originality and relevance to the topics covered in the review.
ReviewIdiopathic intracranial hypertension
Introduction
Idiopathic intracranial hypertension occurs most commonly in overweight women and is encountered by most neurology and ophthalmology departments on a regular basis. Far from being benign, the condition causes blindness in 10% of cases; indeed, most affected patients show a degree of visual loss.1, 2, 3 The association with obesity suggests that the incidence will increase as the population in the developed world gains weight. Despite this theory, very little is known about the disorder. The cause is undetermined and treatments lack any convincing evidence base. This review will summarise current knowledge of the cause, differential diagnosis, and pathophysiology of idiopathic intracranial hypertension, drawing attention to dilemmas in treatment and the need for well-designed prospective trials.
Section snippets
Definitions
Idiopathic intracranial hypertension is the clinical syndrome of raised intracranial pressure, in the absence of space-occupying lesions or vascular lesions, without enlargement of the cerebral ventricles, for which no causative factor can be identified. Serous meningitis and pseudotumour cerebri were the terms previously used for idiopathic intracranial hypertension. In 1937, diagnostic criteria for intracranial pressure without brain tumour were first published by Dandy,4 and in 1955 Foley5
Epidemiology
In the USA, Durcan7 reported the annual incidence of idiopathic intracranial hypertension in the general population of Iowa to be 0·9 per 100 000 and in Louisiana to be 1·07 per 100 000. A prospective longitudinal study in Benghazi, Libya, reported an annual incidence of 2·2 per 100 000.8 In Hokkaido, Japan, only two cases were identifed from the study in 1993, of a population of around 5·8 million, giving an incidence for that year of 0·03 per 100 000.9 The incidence of idiopathic intracranial
Associated conditions
Apart from female sex and obesity there are no proven associations in idiopathic intracranial hypertension. Whether the raised intracranial pressure is a result of, or occurs by chance in association with, the factor in question is important to establish.
Mechanisms of raised intracranial pressure
The pathophysiology underlying the raised intracranial pressure is unclear. Hypotheses have developed around the main determinants of CSF pressure.
Clinical features
Patients with idiopathic intracranial hypertension can be asymptomatic, but more commonly they complain of the symptoms listed in panel 3. Headache is consistently the most common symptom, occurring in 68–98% of patients3, 8, 13 and featuring as the presenting complaint in many.7 Headache seems to be less common in children than in adults with the disorder.70 Headache can fluctuate and be progressive or permanent. The pain may have similarities to migraine and tension-type headache71 or show
Investigations
Idiopathic intracranial hypertension is a diagnosis of exclusion. Although there are no pathognomonic radiological signs in the disorder, empty sella turcica and variable diminution in ventricular size have been reported, although the latter is debated.75 CT became the investigation of choice until it was superseded by MRI. Posterior scleral flattening (relative to the normal curvature of the globe), prelaminar enhancement of optic nerves, vertical tortuosity of the orbital optic nerves, and
Management
There have been no sufficiently large studies of any treatment modality in idiopathic intracranial hypertension so the evidence base for management decisions is poor. A Cochrane systematic review in 2005 did not find any randomised controlled trials of treatments for the disorder.84 The aim of treatment is to halt or prevent visual loss. Current practice includes a combination of medical therapy, advice for weight reduction where appropriate, and surgical intervention for severe cases. Repeated
Outcome
For most patients, idiopathic intracranial hypertension lives up to its old name as a benign condition, without impairment of vision in the long term. However, a small but significant number of patients with idiopathic intracranial hypertension follow a more aggressive course. Blindness has been shown to occur in at least one eye in 8–10% of patients3, 75 and some sustained loss of vision has been reported in almost half of patients in some studies1, 2, 8, 104 (table). No consistent
Future developments
Many questions remain unanswered about idiopathic intracranial hypertension. Its association with female sex and obesity is striking and its co-occurrence with symptoms of hormonal dysfunction intriguing. Although only a few overweight people develop idiopathic intracranial hypertension, the well-recognised increasing trend towards obesity in today's society suggests that the incidence is likely to increase. Despite the large numbers of people affected, especially obese women of childbearing
Search strategy and selection criteria
References (104)
- et al.
Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study
J Neurol Sci
(1993) - et al.
Clinical Characterisation of idiopathic intracranial hypertension at the Detroit medical centre
J Neurol Sci
(2004) - et al.
Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia
J Lab Clin Med
(2005) - et al.
Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome
Am J Ophthalmol
(1999) - et al.
Minocycline treatment and pseudotumor cerebri syndrome
Am J Ophthalmol
(1998) - et al.
Idiopathic intracranial hypertension in cystinosis
J Pediatrics
(2004) - et al.
Magnetic resonance imaging in pseudotumor cerebri
Ophthalmology
(1998) - et al.
Differential diagnosis of patients with intracranial sinus venous thrombosis related isolated intracranial hypertension from those with idiopathic intracranial hypertension
J Neurol Sci
(2003) - et al.
The use of acetazolamide in idiopathic intracranial hypertension during pregnancy
AmJ Ophthalmol
(2005) - et al.
High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri
Am J Ophthalmol
(1994)
The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)
Ophthalmology
Pseudotumor cerebri and optic nerve sheath decompression
Ophthalmology
Visual loss in pseudotumour cerebri
Arch Neurol
Assessment of visual function in idiopathic intracranial hypertension: a prospective study
Eye
Idiopathic intracranial hypertension: a prospective study of 50 patients
Brain
Intracranial pressure without brain tumour: diagnosis and treatment
Ann Surg
Benign forms of intracranial hypertension—toxic and otitic hydrocephalus
Brain
Diagnostic criteria for idiopathic intracranial hypertension
Neurology
The incidence of pseudotumour cerebri: population studies in Iowa and Louisiana
Arch Neurol
Incidence of idiopathic intracranial hypertension in Hokkaido, the northernmost island of Japan
J Neurol
Epidemiology of idiopathic intracranial hypertension in Israel
J Neuroophthalmol
Idiopathic intracranial hypertension in Dubai: nature and prognosis
Acta Neurol Scand
Idiopathic intracranial hypertension: risk of recurrences
Neurology
Benign intracranial hypertension in children
Pediatrics
The prevalence of overweight and obesity in a childhood population of idiopathic intracranial hypertension
Neuroophthalmology
Idiopathic intracranial hypertension: relation of age and obesity in children
Neurology
The fine structure of vitamin A deficiency II: arachnoid granulations and CSF pressure
Brain
Benign intracranial hypertension induced by deficiency of vitamin A during infancy
Neurology
Serum vitamin A concentration is elevated in idiopathic intracranial hypertension
Neurology
Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension
Neurology
Vitamin A in the cerbrospinal fluid of patients with and without idiopathic intracranial hypertension
Ann Neurol
The outcome of pseudotumor cerebri induced by tetracycline therapy
Acta Neurol Scand
Doxycycline induced intracranial hypertension
BMJ
Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumour cerebri): a case-control study
Neurology
Evidence based or theoretical concern? Pseudotumour cerebri and depression as acitretin side effects
J Drugs Dermatol
Benign intracranial hypertension following corticosteroid withdrawal in childhood
BMJ
Benign intracranial hypertension II: following corticosteroid therapy
Neurology
The search for causes of idiopathic intracranial hypertension: a preliminary case-control study
Arch Neurol
Benign intracranial hypertension IV: menarche
Neurology
Benign intracranial hypertension V: menstrual dysfunction
Neurology
Idiopathic intracranial hypertension: relationship to depression, anxiety, and quality of life
Neurology
The production of cerebrospinal fluid in man and its modification by acetazolamide
J Neurosurg
Headache associated with abnormalities in intracranial structure or function: high cerebrospinal fluid pressure headache and brain tumour
CSF hydrodynamics in idiopathic intracranial hypertension: a long-term study
Neurology
Benign intracranial hypertension II: CSF pressure and circulation
Brain
Idiopathic intracranial hypertension: any light on the mechanism of the raised pressure?
J Neurol Neurosurg Psychiatry
Idiopathic intracranial hypertension: lack of histological evidence for cerebral oedema
Arch Neurol
MR imaging of pseudotumor cerebri
Am J Roentgenol
Increased brain water content in pseudotumour cerebri measured by magnetic resonance imaging of brain water self diffusion
Neurol Res
Increased brain water self-diffusion in patients with idiopathic intracranial hypertension
Am J Neuroradiol
Cited by (242)
Establishing continuum in Transcranial Doppler characteristics of IIH, migraine and healthy controls- An exploratory study
2024, Clinical Neurology and NeurosurgeryMultiple skull base defects in the setting of spontaneous cerebrospinal fluid rhinorrhea; a dual institution view
2024, American Journal of Otolaryngology - Head and Neck Medicine and SurgeryConstipation as a cause of lumboperitoneal shunt dysfunction in a patient with idiopathic intracranial hypertension
2024, Acta Neurologica Belgica